MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$8,181K
Free Cash flow
-$849K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Stock-based compensation
Accrued expenses and other liabi...
Others
Negative Cash Flow Breakdown
Purchases of marketable securiti...
Cost of sales (excluding stock-b...
General and administrative (excl...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue, net
48,140
-95,217
-
139,352
Cost of sales (excluding stock-based compensation)
18,584
-41,548
-
63,219
Amortization - license & ip expense
481
-974
-
1,455
Sales (excluding stock-based compensation)
9,042
-15,833
-
24,646
Marketing (excluding stock-based compensation)
3,358
-6,168
-
8,221
Research and development (excluding stock-based compensation)
8,649
-14,760
-
23,401
General and administrative (excluding stock-based compensation)
14,088
-18,062
-
34,140
Stock-based compensation expense
5,339
-14,198
-
19,059
Other segment items
757
12,729
-
-12,326
Net loss
-12,158
-18,866
-44,076
-22,463
Depreciation and amortization
2,009
1,865
1,896
1,918
Amortization of operating lease-right-of use assets
976
948
1,147
1,142
Stock-based compensation
5,339
4,861
5,527
5,638
Loss on disposal of property and equipment
-138
-55
-60
-102
Provision for credit losses
54
459
311
50
Provision for excess and obsolete inventory
440
193
1,236
132
Deferred income taxes
0
-183
38,576
-2,627
Gain on investments, accretion, and amortization, net
-1,298
-1,255
-1,212
-1,353
Interest expenses for accretion of the legal settlement liabilities
86
-47
-761
141
Other non-cash expense (income), net
-1,588
-236
-
-
Trade accounts receivable
-1,971
-9,645
6,146
587
Inventories
2,859
1,627
-2,051
2,222
Prepaid expenses and other assets
2,249
-3,853
3,353
-1,114
Trade accounts payable
1,740
390
-1,309
588
Accrued expenses and other liabilities
4,117
-3,890
4,709
-1,409
Legal settlement liabilities
-210
-389
-293
-252
Operating lease liabilities
2,082
3,117
-
-1,079
Deferred revenue
-400
1,175
1,736
284
Lease liabilities
-
-
4,146
-
Net cash (used in) operating activities
1,367
-2,736
-771
-3,898
Purchases of marketable securities
-61,303
-95,598
-77,108
-59,624
Proceeds from maturities of marketable securities
70,566
70,714
76,105
79,200
Proceeds from sale of property and equipment
3
6
195
1
Acquisition of business
-
-
0
-
Purchase of property and equipment
2,216
2,168
1,001
657
Purchase of intangible assets
28
33
32
-2
Payment for additional investment in cytek japan, net of cash acquired
-
-
0
-
Net cash (used in) investing activities
7,022
-27,079
-1,842
18,920
Repayment of loan
1,613
869
2,940
145
Proceeds from employee stock purchase plan
851
-
446
0
Payments for taxes related to net share settlement of equity awards
184
239
268
171
Proceeds from issuance of common stock under employee stock plans
91
21
85
137
Proceeds from line of credit
41
5,068
1,416
2,091
Payments for repurchase of shares
0
0
-34
-29
Net cash provided by (used in) financing activities
-814
3,981
-1,226
1,941
Effect of exchange rate changes on cash and cash equivalents
606
646
1,412
846
Net (decrease) in cash and cash equivalents
8,181
-25,188
-2,427
17,810
Cash and cash equivalents at beginning of period
65,665
90,853
93,281
98,745
Cash and cash equivalents at end of period
73,846
65,665
90,853
93,281
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of marketable...
$70,566K
(-48.46%↓ Y/Y)
Stock-based compensation
$5,339K
(-60.22%↓ Y/Y)
Proceeds from sale of
property and equipment
$3K
(-94.64%↓ Y/Y)
Accrued expenses and
other liabilities
$4,117K
(514.48%↑ Y/Y)
Operating lease
liabilities
$2,082K
(194.77%↑ Y/Y)
Depreciation and
amortization
$2,009K
(-46.64%↓ Y/Y)
Trade accounts
receivable
-$1,971K
(72.24%↑ Y/Y)
Trade accounts
payable
$1,740K
(48.85%↑ Y/Y)
Other non-cash
expense (income), net
-$1,588K
Amortization of operating
lease-right-of use assets
$976K
(-53.68%↓ Y/Y)
Provision for excess and
obsolete inventory
$440K
(31.34%↑ Y/Y)
Loss on disposal of
property and equipment
-$138K
(45.45%↑ Y/Y)
Interest expenses for
accretion of the legal...
$86K
(-70.55%↓ Y/Y)
Provision for credit
losses
$54K
(3.85%↑ Y/Y)
Net cash (used in)
investing activities
$7,022K
(200.88%↑ Y/Y)
Net cash (used in)
operating activities
$1,367K
(8141.18%↑ Y/Y)
Canceled cashflow
$63,547K
Effect of exchange rate
changes on cash and cash...
$606K
(128.20%↑ Y/Y)
Canceled cashflow
$19,174K
Total revenue, net
$48,140K
Net (decrease) in
cash and cash...
$8,181K
(135.15%↑ Y/Y)
Canceled cashflow
$814K
Purchases of marketable
securities
-$61,303K
(56.65%↑ Y/Y)
Purchase of property and
equipment
$2,216K
(-8.66%↓ Y/Y)
Purchase of intangible
assets
$28K
(-63.16%↓ Y/Y)
Net loss
-$12,158K
(28.42%↑ Y/Y)
Inventories
$2,859K
(-43.64%↓ Y/Y)
Prepaid expenses and
other assets
$2,249K
(436.75%↑ Y/Y)
Gain on investments,
accretion, and...
-$1,298K
(58.24%↑ Y/Y)
Deferred revenue
-$400K
(-125.30%↓ Y/Y)
Legal settlement
liabilities
-$210K
(64.29%↑ Y/Y)
Proceeds from employee
stock purchase plan
$851K
(21.05%↑ Y/Y)
Proceeds from issuance of
common stock under...
$91K
(-11.65%↓ Y/Y)
Proceeds from line of
credit
$41K
(-98.02%↓ Y/Y)
Canceled cashflow
$48,140K
Net cash provided by
(used in) financing...
-$814K
(94.25%↑ Y/Y)
Canceled cashflow
$983K
Cost of sales
(excluding stock-based...
$18,584K
General and
administrative (excluding...
$14,088K
Sales (excluding
stock-based compensation)
$9,042K
Research and development
(excluding stock-based...
$8,649K
Stock-based compensation
expense
$5,339K
Marketing (excluding
stock-based compensation)
$3,358K
Other segment items
$757K
Amortization - license & ip
expense
$481K
Repayment of loan
$1,613K
(-2.83%↓ Y/Y)
Payments for taxes
related to net share...
$184K
(-20.35%↓ Y/Y)
Buy us a coffee
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)